A Study to Evaluate the Efficacy and Safety of AD-223

Clinical trial NCT06052748 · COMPLETED

Trial details

NCT number: NCT06052748
Sponsor: Addpharma Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypertension,Essential

Start date: 2024-02-15
Primary completion: 2025-03-27
Enrollment: 502

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.